Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Barbara Roniker"'
Autor:
Yuen-lung L. Sing, John A. Delyani, Dwain S. Tolbert, Chyung S. Cook, Brian Whelihan, Barbara Roniker, Stuart Levin, Diane Workman, Ricardo Rocha
Publikováno v:
Cardiovascular Drug Reviews. 19:185-200
Aldosterone, the final product of the renin-angiotensin-aldosterone system (RAAS), is a mineralocorticoid hormone that classically acts, via the mineralocorticoid (aldosterone) receptor, on epithelia of the kidneys, colon, and sweat glands to maintai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40ae3eead4dac3136f156a6684a87a29
https://doi.org/10.1111/j.1527-3466.2001.tb00064.x
https://doi.org/10.1111/j.1527-3466.2001.tb00064.x
Autor:
Jeffrey L. Patrick, Scott Krause, Robert C. Davidson, Myron H. Weinberger, Thomas M. MacDonald, Barbara Roniker, William B. White, Luis M. Ruilope
Publikováno v:
American Heart Journal. 150:426-433
Background Sodium retention and volume expansion, mediated in part by aldosterone, are prominent features in low-renin hypertension. Agents that block aldosterone at its receptor sites, therefore, should have significant clinical benefit in patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95a14f640ca40a78fdbcee2e12d3603b
https://doi.org/10.1016/j.ahj.2004.12.005
https://doi.org/10.1016/j.ahj.2004.12.005
Autor:
Gordon H. Williams, Barbara Roniker, Joanna Niegowska, Luis M. Ruilope, Mark S Kipnes, Ellen Burgess, Jeffrey L. Patrick, R. Kolloch, Scott Krause
Publikováno v:
The American Journal of Cardiology. 93:990-996
This study compared the efficacy and tolerability of eplerenone and enalapril in 499 patients with stage 1 or 2 hypertension who were randomized to receive eplerenone or enalapril for 6 months in a 3-step titration-to-effect study. After 6 months, pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94d148e135d7280ee5ca057c9a58710c
https://doi.org/10.1016/j.amjcard.2004.01.007
https://doi.org/10.1016/j.amjcard.2004.01.007
Publikováno v:
The Journal of Clinical Pharmacology. 43:1203-1210
Since neither angiotensin-converting enzyme inhibitors (ACE-I) nor angiotensin II receptor blockers (ARB) can completely suppress aldosterone levels, there is a need for alternative/supplementary antihypertensive medications, such as the selective al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::002e05c98f93bffc4b2a3ee847005850
https://doi.org/10.1177/0091270003258189
https://doi.org/10.1177/0091270003258189
Autor:
Janice Kuse-Hamilton, Scott Krause, Barbara Roniker, Richard St Hillaire, William B. White, Michael A. Weber, Daniel Duprez
Publikováno v:
Hypertension. 41:1021-1026
Eplerenone is a highly selective aldosterone blocker, which is under development for the treatment of hypertension and heart failure. To assess its usefulness in older patients with systolic hypertension and widened pulse pressure, we compared the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b605f1962a7d555d0bcb41337e82833
https://doi.org/10.1161/01.hyp.0000067463.13172.ea
https://doi.org/10.1161/01.hyp.0000067463.13172.ea
Publikováno v:
American Journal of Hypertension. 15:709-716
Eplerenone, a selective aldosterone blocker (SAB) that is highly specific for the aldosterone receptor, has the potential to be efficacious in the treatment of hypertension.This 8-week, multicenter, double-blind, placebo-controlled trial assessed the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a566c04a61984d8fe98f46dd43919568
https://doi.org/10.1016/s0895-7061(02)02957-6
https://doi.org/10.1016/s0895-7061(02)02957-6
Autor:
Jose Lopez-Sendon, Dan Burns, Richard Bittman, Faiez Zannad, Barbara Roniker, Bertram Pitt, Felipe Martinez, Gordon H. Williams, James D. Neaton, Willem Remme, Jay H. Kleiman, Steve Hurley
Publikováno v:
Cardiovascular Drugs and Therapy. 15:79-87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::279514f7c2293520b0ea573cc1f58074
https://doi.org/10.1023/a:1011119003788
https://doi.org/10.1023/a:1011119003788
Autor:
Robert S. Stern, T Daniel Fakouhi, Barbara Roniker, Nicholas J. Lowe, Teresa Bourget, Edward Allen Swabb
Publikováno v:
Clinical Pharmacology and Therapeutics. 56:587-591
Quinolone antimicrobials absorb ultraviolet radiation and, with appropriate drug concentrations, may cause photoreactions. Photoreactions have been reported for several quinolones, including lomefloxacin, a difluorinated quinolone antimicrobial. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4111221ec405d7bee0b67d3eb377425d
https://doi.org/10.1038/clpt.1994.180
https://doi.org/10.1038/clpt.1994.180
Autor:
Luis M. Ruilope-Urioste, Scott Krause, Jay H. Kleiman, Yves Lacourcière, Barbara Roniker, Ellen Burgess, Clement J. Maurath, Suzanne Oparil
Publikováno v:
Clinical therapeutics. 25(9)
Even within the normal range, aldosterone levels are linked to end-organ toxicity and mortality in patients with hypertension. Treatment with angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers does not sufficiently reduce plasm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ddbb87953a3886b5e1c687658b09d9
https://pubmed.ncbi.nlm.nih.gov/14604739
https://pubmed.ncbi.nlm.nih.gov/14604739
Autor:
Roland Willenbrock, Jay Kleiman, Faiez Zannad, Robert A. Phillips, Gordon H. Williams, Barbara Roniker, Nathaniel Reichek, Bertram Pitt, Scott Krause, Daniel Burns
Publikováno v:
Circulation. 108(15)
Background— Elevated renin-angiotensin-aldosterone system activity correlates with left ventricular hypertrophy (LVH) and cardiovascular risk, but the relative contributions of angiotensin II and aldosterone remain unclear. This study compared LVH
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ce936f7498036ec01f74a97bc2267b8
https://pubmed.ncbi.nlm.nih.gov/15010013
https://pubmed.ncbi.nlm.nih.gov/15010013